December 21, 2017 - New Product Pricing

Start 2018 with the most Cost-Effective CD Antibody Range for Flow Cytometry from Caprico Biotechnologies Inc    


Norcross, Georgia (December 21, 2017)


Caprico Biotechnologies Inc (CBI) today announced the release of new product pricing for its range of anti-human CD purified and fluorophore labeled monoclonal antibodies validated for flow cytometry.    


CBI’s products are gaining a reputation within the market for the highest levels of performance.  Now CBI offers the best market pricing available with list antibody prices as low as $0.39/test making flow cytometry experiments more affordable than ever before.


“Flow cytometry testing can be expensive particularly when performing multiparametric analysis.” said Dr Remus Li, MD, President and CEO. Dr Li added “CBI offers researchers the best combination of quality and price to enable them to perform the most cost-effective flow cytometry testing.”


All of CBI’s products are available directly or via CBI’s global distribution network.


For more information, contact:


Punya Mardhanan:      Director of Marketing & Sales

Telephone                   +1 678-691-2143 ext 101




Caprico Biotechnologies Inc (CBI) is a provider of products and services with flow cytometry applications. Core business activities include the production and supply of purified and labeled monoclonal antibodies for immunophenotyping and immunomonitoring and custom hybridoma development and labeling services. For more information about CBI visit their website at


Copyright © 2017 Caprico Biotechnologies Inc, All rights reserved